The antiviral drug "Ingavirin" refers to innovative drugs that have an effective therapeutic effect. Due to the unique formula, the mechanism of action on viral particles, the absence of side effects and a wide range of antiviral activity, this remedy, when used in a timely manner, can significantly reduce the severity of the symptoms of diseases of viral etiology, preventing the development of severe complications.
Start taking the antiviral drug "Ingavirin" in the first two days after the discovery of symptoms of the disease significantly helps to alleviate catarrh, fever, the effects of intoxication and generally reduces the viral load. Despite the low degree of toxicity of the drug (it belongs to the fourth class of low-toxic substances), it should be used for therapeutic purposes strictly observingrecommendations in the instructions.
Medication description
The antiviral agent "Ingavirin" is one of the drugs that are very popular among the population. According to the manufacturer, this tool is very effective and absolutely safe. It is convenient to use and very easy to dose. The drug has an affordable price, and it can also be bought at a pharmacy without a doctor's prescription. In addition, it helps not only with the flu, but also with infections that affect the respiratory tract.
"Ingavirin" is a medicine whose popularity is gaining momentum. This is a good antiviral agent that can be successfully used in the treatment of various infections of the respiratory canals. Respiratory diseases are very common among the population, in connection with this, the demand for medicines from this group is always very high.
Medication Forms
The antiviral agent "Ingavirin" is available in the form of capsules, which differ in the number of active ingredients. In order to protect against accidental replacement and forgery, the capsules are marked with a special symbol - the letter "I" in the ring.
The medicine contains a white powder inside. The manufacturer allows the formation of lumps from the contents of the capsules, which does not affect the effectiveness of Ingavirin and is easily eliminated by lightly pressing the sides of the capsules. It must be remembered that the tablet form of this drug is not available on the pharmacological market.
For the correct and safe selection of dosing, the product is produced in variousoptions:
- In the form of blue 30 mg capsules placed in blister strips. They are placed in a cardboard box. Only one or two blisters, each with seven capsules.
- In the form of yellow capsules of 60 mg. The package contains one cell blister, which contains seven capsules.
- In the form of red capsules. Antiviral agent "Ingavirin" 90 mg is available in the same form as 60 mg.
The drug is also available in packages, which are plastic jars in which capsules are placed. Their number can be from 60 to 90 pieces. This form of packaging is intended for therapy in a hospital, therefore it is not available for free sale.
Composition of the drug
The antiviral drug "Ingavirin" contains the main active ingredient and auxiliary components. The first is imidazolylethanamide pentanedioic acid. Depending on the dosage, its content in one capsule can be 30, 60 or 90 mg.
Additional components include compounds that are produced for the production of the capsule itself. The shell is made from silicon dioxide, magnesium stearate, starch and lactose. Propylene glycol, dyes and small amounts of titanium dioxide are used for coloring and labeling the capsule.
For what diseases is this remedy prescribed?
The antiviral drug "Ingavirin" in low and medium dosage is prescribed for the treatment of children from seven years of age. Also, a medicinal product containing30 and 60 mg of the active substance can be used for prophylactic purposes, when the likelihood of infection is high. For example, in contact with patients. In this case, only use by patients who have reached the age of 18 is allowed. "Ingavirin" 90 mg is intended for the treatment and prevention of diseases only in adults.
Has a pronounced effect on influenza viruses, parainfluenza pathogens, respiratory syncytial infections, adenoviruses and a number of other pathogenic microorganisms. The instructions for use provide recommendations for taking Ingavirin antiviral tablets for the treatment and prevention of diseases of exclusively viral etiology.
Therapeutic effect of the drug
With the timely use of the drug, the following effect can be expected:
- suppression of the ability of viruses to reproduce, thereby reducing the severity of symptoms and the duration of the acute period of the disease;
- preventing the spread of viruses throughout the body;
- production of interferon and leukocytes by the body;
- removing inflammation and reducing the severity of fever, as well as its accompanying symptoms;
- prevent complications.
Pharmacokinetics
As the instructions for the antiviral drug "Ingavirin" say, the use in a therapeutic dosage contributes to the accumulation of the active substance in the tissues already half an hour after ingestion. This drug is almost completely eliminated frombody in a day unchanged. When taken at the recommended dosage, it is not found in the composition of the blood plasma during the study.
The process of excretion of the drug is carried out through the intestines. It is worth noting that up to 77% is displayed in this way. The remaining 23% is excreted by the body through the kidneys.
Dosing, age restrictions and instructions
Antiviral "Ingavirin", regardless of the amount of active substance in one capsule, is taken once a day. During the whole course of treatment or prophylactic administration, it is recommended to adhere to one specific time of administration in order to ensure the greatest therapeutic or protective effect. The use of the drug does not depend on the diet and time of eating. Capsules should be taken with plenty of liquid. They must be swallowed whole, not opened or bitten.
The duration of the course for therapeutic and prophylactic purposes is the same, and ranges from five to seven days. The duration of the course and the appropriate dosage can be determined solely by the attending physician, taking into account the individual characteristics of the patient's body, age, the presence of concomitant diseases and the course of infectious pathologies.
Treatment of influenza and respiratory viral infections in children aged seven to seventeen is carried out by taking Ingavirin at a dosage of 60 mg (one 60 mg capsule or two 30 mg capsules).
90 mg dosageintended for the treatment and prevention of viral pathologies in adults. The effectiveness of this drug is ensured by the early start of administration, which should occur no later than 36 hours from the onset of the first symptoms of a viral disease, or from the moment when contact with the patient occurred. For preventive and therapeutic purposes, take one capsule per day for five days.
Contraindications to taking the medicine and its possible side effects
The drug "Ingavirin" is prohibited for admission in early childhood. In addition, the possibility of increasing the daily dosage from 60 mg to 90 mg for children under 18 years of age is excluded.
Despite the absence of any data on the relative teratogenic and embryotoxic effects, as well as the negative impact on reproductive activity, this drug cannot be prescribed for use during the period of gestation due to the ability of the drug to activate the body's defenses, which, in turn, can provoke the process of fetal rejection.
Due to the fact that no study was conducted on the ability of the active substance to penetrate into breast milk and the likelihood of a negative effect on the baby's body was not determined, the drug "Ingavirin" is strictly contraindicated during lactation. If antiviral therapy is needed, breastfeeding is stopped for this time.
With great care, this remedy is prescribed for lactase deficiency, against the background oflactose intolerance, with sensitivity to the base and accompanying components of the drug. A side effect may be an allergic reaction.
Before use, you must carefully read the instructions for the antiviral drug "Ingavirin". It is recommended to consult your doctor beforehand.
Compatibility with other drugs and alcohol
In experiments, there is an increased effectiveness of Ingaverin in the treatment of bacterial and viral infections, with secondary pneumonia and bronchitis in combination therapy with antibacterial agents.
Studies on the interaction of this drug with ethanol have not been conducted, however, during the period of treatment and prevention, it is recommended to refrain from drinks containing alcohol.
The antiviral drug "Ingavirin" does not have a sedative effect and does not have any effect on psychomotor reactions, and therefore it can be used while driving a car or during periods of work that requires increased coordination of movements and concentration attention.
Analogues
Medications that contain the same active ingredient as Ingaverin are Vitaglutama and Dicarbamine. Their impact is based on a similar component.
It is also necessary to highlight other antiviral drugs that have a wide range of effects against similar types of infectious agents. These can be attributedAmiksin, Ribavirin, Tamiflu, Remantadin and many others. However, if there is a need to replace Ingavirin with a similar remedy, it is imperative to consult with a specialist.
Antiviral drug for children "Ingavirin"
The use of funds in pediatrics is allowed only if the child is already seven years old. To date, it has not been completely studied how the drug will affect the body of a young child, since no relevant clinical studies have been conducted. This means that the safety and effectiveness of this drug in children under seven years of age has not been confirmed by any medical research. Thus, this factor alone suggests that the antiviral "Ingavirin" should not be used for young children, since it is not known what consequences this may have for the child's body.
In addition, you need to know that the history of the drug is much longer than it might seem at first glance, and there are very serious factors in it that indicate the need to abandon the use of this drug in the treatment of infectious diseases in children. The fact is that the drug in question was registered and released to the pharmaceutical market as an antiviral agent only ten years ago, and it was synthesized back in the seventies of the last century. After receiving this drug in the 70s, it was used as a stimulant of hematopoietic processes in people who received chemotherapy forremoval of a malignant tumor. In principle, the drug in question is still used in oncological practice, however, under a different name.
Thus, it is quite obvious that the antiviral agent "Ingavirin" can affect the processes of hematopoiesis, which can provoke extremely negative consequences for children. After all, the regulation system in children is not as perfect and stable as in adult patients, as a result of which even minimal interventions in their work can lead to negative consequences and the development of serious diseases. It is because of this potential danger that it is not recommended to use Ingavirin in the treatment of influenza and acute respiratory viral infections among children under the age of 18 years. For the treatment of babies, it is best to use safer analogues. For example, these are antiviral agents such as Arbidol and Anaferon.
Opinions of doctors and patients
Reviews about the antiviral "Ingavirin" are ambiguous. Half of them are positive, and the other half are negative.
Those people who speak positively about the drug indicate in the comments that this antiviral agent greatly facilitates the course of influenza and otolaryngological diseases, and also helps to speed up recovery and reduce the period of illness to five days, as stated in the instructions.
In negative reviews, patients note that Ingaverin does not produce any noticeable effectduring treatment, as a result of which the severity of symptoms does not decrease and the duration of the disease does not decrease. Thus, we can conclude that the drug is not effective in all cases.
Also on the forums you can find reviews of doctors about the antiviral "Ingavirin". Here the situation is the same: someone writes good comments about him, and someone writes bad ones. Doctors point out that after the start of taking the drug, patients have a sharp increase in blood pressure, which is then difficult to normalize, as a result of which patients have to go to a medical institution to stop the emerging hypertensive crisis. Specialists associate a similar effect of Ingavirin, primarily with its negative effect on the kidneys. As a result, urine excretion slows down and, accordingly, against this background, there is a sharp increase in pressure.
In connection with this, people who suffer from some kind of kidney disease must be careful when taking Ingavirin. You should also pay attention to blood pressure, periodically measuring it. In the event that it rises sharply, you should immediately stop using the medication and seek help from a specialized medical institution.
The instructions for the antiviral drug "Ingavirin" were presented above, the rules for taking it were described and reviews were considered, on the basis of which you can decide whether to buy this drug.
